Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: bob kubecka who wrote (43159)	11/16/2005 10:19:10 AM
From: Celtictrader	Respond to of 120413

Looking to join you,just came across this post on r.b. MKRS story in this am's Trenton Times: nj.com W. Windsor firm will put radar testing device to test Tuesday, April 12, 2005 By TRACEY L. REGAN Staff Writer WEST WINDSOR - Mikros Systems Corp., a wireless technology company, said it will soon test its credit-card-size device for testing and maintaining radar and sonar systems on U.S. Navy ships. "We are building about five systems to place on ships," said Thomas Meaney, president and CEO of the Alexander Road company, noting that the first ships to use them will be the Navy's Aegis cruisers. The equipment will be tested on land this spring and, about a year from now, at sea. It will perform such diagnostic tests as determining whether radar systems are out of alignment. The company was awarded a small business research grant last September from the Naval Weapons Center in Dahlgren, Va. - valued at approximately $2.4 million - to complete the development and begin initial production of the testing system. Meaney described the equipment, which is a small printed circuit card just slightly larger than a credit card, as "a compact way to lug around a lot of testing equipment." People testing equipment now have to carry "a lot of paper documentation and we're building it all into the computer," he said. "It will prompt the operator." Mikros Systems has subcontracted the manufacturing of its equipment, to be marketed under the name ADEPT (Adaptive Diagnostic Electronic Portable Testset), to DRS Laurel Technologies in Johnstown, Pa. Ships will use anywhere from one to three of the devices, Meaney said, adding, "We haven't figured out what they will cost yet." He added that there are 80 ships equipped with Aegis systems, which are built by Lockheed Martin in Moorestown, and another 60 to 70 amphibious carriers that could potentially use the equipment. Meaney said the device has commercial applications as well, and could be used to test commercial radars and other complex electronic equipment such as radio and TV stations, cell phone stations and airline maintenance equipment. "We are hoping to get the FAA (Federal Aviation Administration), radio stations and TV to use them as testing devices," he said. Last year, the company teamed with DRS Technologies of Parsippany to win a $100,000 contract from the U.S. Navy to develop a technology that would allow military radar systems to coexist with commercial wireless communications systems. Current radar systems create interference with commercial TV signals when they come into port, requiring navy vessels to turn them off at times. The company reported revenues for the year ended Dec. 31 of approximately $1 million with net income of approximately $92,000, compared to $231,000 in revenues in 2003 with a net loss of approximately $114,000. Mikros currently has about $2 million in back orders. ragingbull.lycos.com

To: bob kubecka who wrote (43159)	11/16/2005 10:19:12 AM
From: Motlink	Read Replies (1) \| Respond to of 120413

IAGX... up .30 to 2.65 I especially like the part about the first 12 months revenue of between $10 and $15 million. They were late last quarter and looks like they are late again with filing. Should see it any time now. Imagenetix Licenses Patent Related to Body Fat Control; Commercialization of Fat Reduction Product to Commence Immediately November 16, 2005 08:30:02 (ET) SAN DIEGO, Nov 16, 2005 (BUSINESS WIRE) -- Imagenetix, Inc. (IAGX, Trade), an innovator of scientifically tested, natural-based, proprietary bioceutical products that enhance human health, today announced it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage. The compound, branded as Lepitrim(TM), will be marketed immediately by Imagenetix and its distribution partners across the U.S. and Canada. Product revenue to Imagenetix during the first 12 months is expected to be between $10 and $15 million, said the company. Lepitrim(TM) is not a drug, but is comprised of natural polysaccharide compounds which have been found in animal studies conducted at the University of Minnesota to lower serum leptin levels and reduce stored body fat with no side effects. Imagenetix CEO William P. Spencer said: "We are very excited about the results of recent research on the role of leptin in fat utilization and regulation. We believe that Lepitrim(TM) will provide immediate and longer term assistance to the countless number of individuals that have tried and failed to lose body fat using other weight management programs. "We have therefore begun to initiate comprehensive distribution and marketing strategies for Lepitrim(TM) with our marketing partners and are optimistic the product will carve out a significant market niche for years to come." According to the National Center for Health Statistics, 65 percent of Americans are either overweight or obese. In 2004, nearly $150 billion was spent in the U.S. on obesity-related products. Imagenetix, Inc. (IAGX), www.imagenetix.net, develops, formulates, private-labels, and produces nutritional supplements, over-the-counter topical creams, skin care products and pharmaceuticals for inflammatory-related markets.